| Views | |
|---|---|
| Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 458 |
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 30 | 21 | 14 | 44 | 15 | 29 | 15 |
| Views | |
|---|---|
| art_3A10.1186_2Fs13195-016-0189-7.pdf | 267 |
